Entrada Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of TRDA for the last quarter is 41.85 M USD, and it's 4.31% lower compared to the previous quarter. The net income of Q4 23 is -9.54 M USD.